Table 1:
Baseline characteristics of the cohort.
| ATN | AIN | ||
|---|---|---|---|
| N = 21 | N = 37 | P value | |
| Age | 66.5 ± 11.9 | 68.19 ± 11.91 | P = .54 |
| Sex (male) | 15/21 (71, 42%) | 21/37 (56.76%) | P = .4 |
| Creatinine (µmol/l, median [IQR]) | 250 [162.5–585.5] | 209 [173–389.5] | P = .59 |
| Hypertension (% patients) | 14/21 (66.67%) | 23/37 (62.16%) | P = .78 |
| Diabetes (%patients) | 8/21 (38.1%) | 8/37 (21.62) | P = .23 |
| Pre-existing CKD (%patients) | 7/21 (33.33%) | 6/37 (16.22) | P = .19 |
| C-reactive protein (mg/l, median [IQR]) | 8.6 [5.33–21.28] | 34.85 [8.9–81.1] | P = .03a |
| Leukocyturiaa (%patients) | 14/21 (66.67%) | 32/37 (86.48%) | P = .097 |
| Microhaematuria (%patients) | 8/21 (38.1%) | 7/37 (18.92%) | P = .13 |
| Eosinophilia (%patients) | 0/21 (0%) | 8/37 (21.62%) | P = .041a |
| Leukocytosis (%patients) | 6/21 (28.57%) | 11/37 (29.73%) | P > .99 |
CKD: Chronic Kidney Disease.
aLeukocyturia: > 12 leukocytes/microliter.